Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational

A Study of Elecsys® Troponin T hs Gen 6 in Participants With Symptoms of Acute Coronary Syndrome

ClinicalTrials.gov ID: NCT06734117

Public ClinicalTrials.gov record NCT06734117. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 1:11 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Clinical Performance of Elecsys® Troponin T hs Gen 6 in Subjects With Symptoms of Acute Coronary Syndrome

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This prospective, non-interventional, single arm, longitudinal cohort multicenter study will recruit approximately 5600 consecutive all-comers, consisting of patients with signs and symptoms of acute coronary syndromes (ACS) who present in the emergency department (ED). The main objective of the study is to determine the clinical performance of Elecsys Troponin T hs Gen 6 versus the centrally adjudicated clinical diagnosis at various time points after ED presentation using the previously determined clinical cut-off of a universal 99th percentile upper reference limit.

Study identification

NCT ID
NCT06734117
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Lead sponsor
Hoffmann-La Roche
Industry
Enrollment
5,429 participants

Conditions and interventions

Interventions

Diagnostic Test · Procedure

Eligibility (public fields only)

Age range
20 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 15, 2021 (Actual)
Primary completion
Jun 27, 2024 (Actual)
Completion
Dec 26, 2024 (Actual)
Last update posted
Jan 24, 2025

2021 – 2024

United States locations

U.S. sites
26
U.S. states
14
U.S. cities
24
Facility City State ZIP Site status
El Centro Regional Medical Center El Centro California 92243 —
UCSD La Jolla ED La Jolla California 92037 —
University of Florida Gainesville Florida 32610 —
Tampa General Hospital Tampa Florida 33606 —
Parkview Research Fort Wayne Indiana 46845 —
University of Kansas Medical Center Kansas City Kansas 66160 —
Henry Ford Health Detroit Michigan 48202 —
Minneapolis Heart Institute Foundation Minneapolis Minnesota 55407 —
University at Buffalo / Buffalo General Hospital Buffalo New York 14203 —
University of Buffalo - Erie County Medical Center Buffalo New York 14215 —
Long Island Jewish Medical Center New Hyde Park New York 11040 —
Atrium Health Charlotte North Carolina 28203 —
Duke Regional Hospital Durham North Carolina 27704 —
Duke University Durham North Carolina 27710 —
Atrium Health Wake Forest Baptist, High Point Medical Center High Point North Carolina 27262 —
Wake Forest Health Sciences Winston-Salem North Carolina 27157 —
Oklahoma Heart Hospital Oklahoma City Oklahoma 73135-2607 —
Medical University of South Carolina Charleston South Carolina 29425 —
MUSC Health Florence Medical Center Florence South Carolina 29505 —
Dallas VA Medical Center Dallas Texas 75216 —
Baylor College of Medicine Houston Texas 77030-2348 —
Inova Fairfax Hospital Falls Church Virginia 22042 —
Sentara Norfolk General Hospital Norfolk Virginia 23507 —
Eastside Research Associates Redmond Washington 98052 —
MultiCare Institute for Research & Innovation Tacoma Washington 98405 —
Aspirus Medical Group Wausau Wisconsin 54401-4173 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 24 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06734117, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 24, 2025 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06734117 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →